Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Journal of Proteome Research|March 12, 2025
Pilot Study of Metabolomic Biomarkers Associated with Outcomes in Patients with Lung Cancer Undergoing Radiation TherapyWei Meng, Rui Xu, Eric Miller, et al.International Journal of Radiation Oncology, Biology, Physics|April 23, 2022
68Ga-DOTATATE PET-Based Radiation Contouring Creates More Precise Radiation Volumes for Patients With MeningiomaHaley K Perlow, Michael Siedow, Yevgeniya Gokun, et al.Frontiers in Oncology|October 23, 2023
A plasma miRNA-based classifier for small cell lung cancer diagnosisMichela Saviana, Giulia Romano, Joseph McElroy, et al.Journal of Genetic Counseling|February 21, 2018
Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and TestingTara Schmidlen, Amy C Sturm, Shelly Hovick, et al.Cancers|April 27, 2024
Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse AstrocytomasAline P Becker, Valesio Becker, Joseph McElroy, et al.International Journal of Radiation Oncology, Biology, Physics|December 25, 2018
MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality TreatmentWei Meng, Jason Efstathiou, Rajbir Singh, et al.Oncotarget|November 12, 2016
Discovery and replication of microRNAs for breast cancer risk using genome-wide profilingCenny Taslim, Daniel Y Weng, Theodore M Brasky, et al.Oncogene|December 19, 2018
miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastomaTiantian Cui, Erica H Bell, Joseph McElroy, et al.International Journal of Radiation Oncology, Biology, Physics|February 22, 2024
A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung CancerTerence M Williams, Eric Miller, Meng Welliver, et al.Molecular Cancer Research : MCR|September 25, 2020
A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in GlioblastomaTiantian Cui, Erica H Bell, Joseph McElroy, et al.Pageof 3